Distinctive gene transduction efficiencies of commonly used viral vectors in the retina

Current Eye Research

Volumn 33, Issue 1, 2008, Pages 81-90

  Zhang, Sheng Hai ^a   Wu, Ji Hong ^a   Wu, Xiao Bing ^b   Dong, Xiao Yan ^b   Liu, Xin Jian ^a   Li, Chuan Yuan ^c   Huang, Qian ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b National Institute for Viral Disease Control and Prevention   (China)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Gene transduction efficiency; Retina; Transgene expression pattern; Viral vector; Viral vector tropism

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; VIRUS RECEPTOR; VIRUS VECTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; RETINA CELL; RETINA DISEASE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ADULT; ANIMALS; ANTIGENS, CD46; CELLS, CULTURED; DEPENDOVIRUS; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPARAN SULFATE PROTEOGLYCANS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRINS; PIGMENT EPITHELIUM OF EYE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VIRUS; RECEPTORS, VITRONECTIN; RETINA; TRANSDUCTION, GENETIC; TROPISM;

EID: 38549096980     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701799408     Document Type: Article

References (30)

1. Congdon N, O'Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
2. Rodriguez J, Sanchez R, Munoz B, West SK, Broman A, Snyder RW, Klein R, Quigley H. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology. 2002;109:737-743.
3. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol. 1991;109:1232-1241. http://archopht.amaassn.org/cgi/content/abstract/109/9/1232.
4. Chaum E. Retinal neuroprotection by growth factors: A mechanistic perspective. J Cell Biochem. 2003;88:57-75.
5. King GL, Suzum K. Pigment-epithelium-derived factor - A key coordinator of retinal neuronal and vascular functions. N Engl J Med. 2000;342:349-351.
6. Thanos C, Emerich D. Delivery of neurotrophic factors and therapeutic proteins for retinal diseases. Expert Opin Biol Ther. 2005;5:1443-1452.
7. Bainbridge JW, Tan MH, Ali RR. Gene therapy progress and prospects: The eye. Gene Ther. 2006;13:1191-1197.
8. Dinculescu A, Glushakova L, Min SH, Hauswirth WW. Adeno-associated virus-vectored gene therapy for retinal disease. Hum Gene Ther. 2005;16:649-663.
9. Auricchio A, Rolling F. Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases. Curr Gene Ther. 2005;5:339-348.
10. Verma IM, Weitzman MD. Gene therapy: Twenty-first century medicine. Annu Rev Biochem. 2005;74:711-738.
11. Young LS, Searle PF, Onion D, Mautner V. Viral gene therapy strategies: From basic science to clinical application.J Pathol. 2006;208:299-318.
12. Anglade E, Csaky KG. Recombinant adenovirus-mediated gene transfer into the adult rat retina. Curr Eye Res. 1998;17(3):316-321.
13. Liu XY, Gu JF. Targeting gene-virotherapy of cancer. Cell Res. 2006;16(1):25-30.
14. Kushwah R, Cao H, et al. Potential of helper-dependent adenoviral vectors in modulating airway innate immunity. Cell Mol Immunol. 2007;4(2):81-89.
15. Grant C, Ponnazhagan S, et al. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina. Curr Eye Res. 1997;16(9):949-956.
16. Philpott NJ, Thrasher AJ. Use of nonintegrating lentiviral vectors for gene therapy. Hum Gene Ther. 2007;18(6):483-489.
17. Martin KR, Klein RL, Quigley HA. Gene delivery to the eye using adeno-associated viral vectors. Methods. 2002;28:267-275.
18. Burger C, Gorbatyuk OS, et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther. 2004;10(2):302-317.
19. DiPaolo N, Ni S, Gagga AR, Strauss R, Tuve S, Li ZY, Stone D, Shayakhmetov D, Kiviat N, Toure P, Sow S, Horvat B, Lieber A. Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination. Mol Ther. 2006;13:756-765.
20. Yotnda P, Onishi H, Heslop HE, Shayakhmetov D, Lieber A, Brenner M, Davis A. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther. 2001;8:930-937.
21. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Ther. 2003;10:977-982.
22. Stramm LE, Pautler EL. Transport of 3-O-methylglucose in isolated rat retinal pigment epithelial cells. Exp Eye Res. 1982;35:91-97.
23. Dull T, Zufferey R, Kelly M, Mandel RJ, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72: 8463-8471.
24. Duisit G, Conrath H, Saleun S, Folliot S, Provost N, Cosset FL, Sandrin V, Moullier P, Rolling F. Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat. Mol Ther. 2002;6:446-454.
25. Kimio A, Barnstable C. Identification and characterization of cell types in monolayer cultures of rat retina using monoclonal antibodies. Brain Research. 1986;383:110-120.
26. Bergelson JM, Cunningham JA, Droguett, G., et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320-1323.
27. Joshua NM, Hurwitz M, Maboney T, et al. Efficient gene transfer into retinal cells using adenoviral vectors: Dependence on receptor expression. Invest Ophthalmol Vis Sci. 2004;45(6):1680-1687.
28. Vives RR, Lortat-Jacob H, Fender P. Heparan sulphate proteoglycans and viral vectors : Ally or foe? Curr Gene Ther. 2006;6(1):35-44.
29. Summerford C, Bartlett JS, Samulski RJ. AlphaVbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection. Nat Med. 1999;5(1):78-82.
30. Pang J, Cheng M, Haire SE, Barker E, Planelles V, Blanks JC. Efficiency of lentiviral transduction during development in normal and rd mice. Mol Vis. 2006;12:756-767.